Evidence map›Paper›PMID 42060514›Full record

ArticleEndocrinology, diabetes & metabolism2026

Methodological Shortcomings in a Study of Peripheral Circulatory Complications in Type 2 Diabetes.

Ahmar Jan Qureshi, Muhammad Riyyan Tariq Tagga, Raghabendra Kumar Mahato

Abstract readLetter
In one paragraph

Article in Endocrinology, diabetes & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ahmar Jan QureshiCMH Multan Institute of Medical Sciences, Multan, Pakistan.ORCID https://orcid.org/0009-0007-4096-2430
Muhammad Riyyan Tariq TaggaCMH Multan Institute of Medical Sciences, Multan, Pakistan.ORCID https://orcid.org/0009-0008-4739-3055
Raghabendra Kumar MahatoGandaki Medical College Teaching Hospital and Research Center, Pokhara, Nepal.ORCID https://orcid.org/0009-0009-9434-1650

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis critique examines the methodological quality of a recent study by Shahid et al. on mortality trends related to peripheral circulatory complications in patients with type 2 diabetes mellitus using the CDC WONDER database.

methodsWe critically appraised the original study's methodology, including the consistency of reported mortality rates, age group data presentation, classification of urban and rural areas, reporting of race and ethnicity data, place of death analysis and causal inferences drawn from the ecological design.

resultsSeveral methodological shortcomings were identified: inconsistent reporting of mortality rate denominators (per 100,000 vs. per 1,000,000 population); selective reporting of age group data in the main text; use of a non-standard threshold (500,000 population) for classifying urban and rural areas; inconsistent use of the 'Non-Hispanic' qualifier for race and ethnicity categories; percentages summing to over 100% in the place of death analysis; and unsupported causal claims in the discussion.

conclusionsWhile the original study addresses an important public health concern, the identified methodological issues limit the interpretability of its findings. Addressing these concerns through consistent denominators, complete age-stratified reporting and standard classifications would strengthen future research in this area.

Indexed as

Diabetes Mellitus, Type 2Diabetic AngiopathiesPeripheral Vascular DiseasesResearch DesignHumansUnited Statesdiabetes mellitus‐type 2mortalityperipheral vascular diseases

Identifiers

PMID42060514
PMCPMC13132024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.